NCT00061529View on ClinicalTrials.gov

A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2003

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Brimonidine Tartrate Ophthalmic Solution

Trial Locations (1)

Unknown

Alcon Call Center, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00061529 - A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter